Atlas Trials

The Safety of Nafamostat Mesylate for Patients With High Risk Bleeding Undergoing Hemodialysis: A Pilot Study

Clinical trial NCT05874674 · RECRUITING

Trial details

NCT number
NCT05874674
Sponsor
Wonju Severance Christian Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Dialysis; ComplicationsBleeding
Start date
2023-12-01
Primary completion
2025-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.